Please login to the form below
Middle East
This page shows the latest Middle East news and features for those working in and with pharma, biotech and healthcare.
J&J’s multiple sclerosis therapy Ponvory moves closer to EU approval
Relapsing forms of multiple sclerosis have varied and often unpredictable symptoms, posing a unique human, societal and economic burden,” said Catherine Taylor, vice president, medical affairs therapeutic area strategy, Europe, Middle ... East and
Latest news
-
bluebird bio marks Rare Disease Day 2021 with launch of patient testimonial video
Although there are many cases of thalassaemia among people of Mediterranean, Middle Eastern, South and East Asian and African descent, global population movements mean that the disease now occurs across the
-
Janssen’s Erleada improves survival in certain advanced prostate cancer patients
cancer,” said Catherine Taylor, vice-president, medical affairs therapeutic area strategy for Europe, Middle East and Africa, Johnson &Johnson Middle East.
-
Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer
for Europe, Middle East and Africa at Janssen.
-
Merck signs separate agreements with Seattle Genetics for two cancer drugs
In a separate agreement, Seattle Genetics has granted Merck an exclusive license to commercialise Tukysa (tucatinib), a small molecule tyrosine kinase inhibitor, in Asia, the Middle East, Latin America and other
-
Takeda to sell Japan consumer health unit for $2.3bn
This included offloading a number of its OTC and prescription medicines in emerging markets in Near East, Middle East and Africa (NEMEA) countries to Acino for $200m.
More from news
Approximately 1 fully matching, plus 135 partially matching documents found.
Latest Intelligence
-
Unlocking the potential of precision medicine in oncology
More specifically, through our ORACULUM studies, we are using AI to analyse patient-level data that is collected through electronic health records across numerous countries in Europe, the Middle East and
-
As COVID-19 takes over the world, biopharma fights back
respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).
-
Keeping up the fight against HIV and using the lessons to tackle other threats
their big budget spreadsheets,” said Mike Elliott (pictured above), Vice President of Medical Affairs for Europe, Middle East &Australasia for Gilead Sciences.
-
Leading AstraZeneca’s return to growth in Europe
Care in Central and Eastern Europe, Middle East and Africa before landing the general manager role in Russia in 2014.
-
Bluebird: on a mission to ‘recode’ the DNA of healthcare
Obenshain insisted, however, that Bluebird is investing for a long-term independent future, with its sights also set on taking Zynteglo into the Middle East and Asia, where beta thalassemia patients
More from intelligence
Approximately 0 fully matching, plus 31 partially matching documents found.
Latest appointments
-
GCI Health’s UK team announces three senior promotions
Walker, Morris and Yianni will report to Kath Kerry, who was recently named as GCI Health's president of Europe &Middle East.
-
New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics
Umberto La Magna has decided to join Sinclair Pharma, taking up the role of head of Central and Eastern Europe and Middle East and Africa regions. ... Most recently, La Magna held the role of head of central south-east Europe for Baxter International,
-
Pharnext appoints COO
Before joining Pharnext, Kohli was general manager of clinical diagnostics at Eurofins based in Brussels, where he led business expansion across Europe and the Middle East.
-
Anish Mehta appointed CEO of new women's health business
Prior to his new role, Mehta has served at Actavis, taking the helm of its European and Middle East business, where he managed a portfolio of pharmaceutical products.
-
Bayer UK and Ireland appoints new CEO
Prior to that Bruening held senior commercial roles in Europe, the Middle East and Asia, bringing knowledge in the pharmaceutical sector, international healthcare landscape and global commercial markets to the group.
More from appointments
Approximately 0 fully matching, plus 34 partially matching documents found.
Latest from PMHub
-
Dovetail partners with Tillotts AG to map management of C. difficile infection in Europe
Tillotts Pharma AG recently acquired the rights to DIFICLIR from Astellas Pharma Europe Ltd for Europe, Middle East, Africa and selected CIS.
-
Lucid Group Evolve and Simplify its Brand Architecture
Seven months later, in September 2019, Lucid Group acquired HealthCare21 – increasing its footprint in the UK, Asia Pacific and Middle East along with specific expertise in digital strategy, medical writing, editing
-
GLOBALHealthPR® Welcomes Exclusive France Partner Agency
GLOBALHealthPR's presence spans more than 60 countries, covering Europe, North America, Latin America, the Middle East, Africa and Asia-Pacific.
-
It’s Teenage Kicks for Lucid Group
s footprint into Asia Pacific, Africa and Middle East region, and the north west of England, coupled with its highly regarded reputation for scientific content, editorial excellence and digital capability, including
-
Hanover Health launches the Mackay Programme
Opportunities to work with colleagues in our Brussels, Dublin and Middle East offices.
More from PMHub
Approximately 0 fully matching, plus 25 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Content Editor - Biotechnology
-
Salary TBC
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
-
Principal Medical Writer
-
Varies on experience
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- Oxford University to investigate nasal spray delivery of AZ-partnered COVID-19 vaccine
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- Bedrock Group rebrands as Resonant Group
- New restrictions for AZ/Oxford COVID-19 vaccine despite EMA endorsement
- Moderna launches COVID-19 vaccine booster study to address new variants
- Live Webinar: Nanobiotechnology, Artificial Intelligence, and Virtual Care
- Opdivo improves survival in oesophageal cancer
- Keytruda shows significant and meaningfully improvement in kidney cancer
- Congress 2020 BC (before COVID-19)
- Shaping the Future of Medicine, Science, and Technology
- Live Webinar: Virtual Trials, Remote Care, & Cross-Border Collaboration: Ethical & Legal Challenges
PMHub
Mind+Matter
We are Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for our...
Latest intelligence
- Virtual congresses: video thrilled the cardio tsar
- Chris Ross explores the key learnings from a year of virtual congresses...
- When Will We Be Back To Normal?
- The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
- How to tell your healthcare story.
- Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....
Quick links
Infographics
